Alba Dalmases Massegú

Title: Alba Dalmases Massegú: Innovator in Cancer Treatment

Introduction

Alba Dalmases Massegú is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and patented inventions. With a total of 2 patents, her work focuses on identifying mutations in the epidermal growth factor receptor gene, which plays a crucial role in cancer therapy.

Latest Patents

Massegú's latest patents include a method of treating cancer based on identifying mutations in the extracellular domain III of the epidermal growth factor receptor gene. This invention relates to newly identified mutations that lead to amino acid changes, which are highly correlated with resistance to a therapy regimen comprising cetuximab. The invention encompasses peptide sequences and primers to detect these mutations, as well as kits designed to predict a subject's response to cetuximab therapy. This method is particularly useful for treating metastatic colorectal cancer.

Another significant patent by Massegú involves a newly identified mutation in the epidermal growth factor receptor gene, which also leads to an amino acid change. This mutation is associated with resistance to cetuximab and sensitivity to panitumumab therapy. Similar to her previous invention, this patent includes peptide sequences, primers, and probes for detecting the mutation, along with kits for predicting responses to therapy regimens involving cetuximab and/or panitumumab. This invention is applicable to both metastatic colorectal cancer and head and neck cancer.

Career Highlights

Throughout her career, Alba Dalmases Massegú has worked with notable organizations, including the Fundació Institut Mar d'Investigacions Mèdiques (IMIM). Her research has significantly advanced the understanding of cancer treatment and has the potential to improve patient outcomes.

Collaborations

Massegú has collaborated with esteemed colleagues such as Clara Montagut Viladot and Joan Albanell Mestres. These partnerships have fostered a collaborative environment that enhances the innovation process in cancer research.

Conclusion

Alba Dalmases Massegú is a trailblazer in the field of cancer treatment, with her innovative patents paving the way for more effective therapies. Her work exemplifies the importance of research and collaboration in advancing medical science.